about
Development of lacosamide for the treatment of partial-onset seizuresClinical trial of vigabatrin as adjunctive therapy in children with refractory epilepsy.Rational Polytherapy with Antiepileptic Drugs.Update on treatment of partial onset epilepsy: role of eslicarbazepineEmerging drugs for epilepsy.Treatment of epilepsy in China: Formal or informal.Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapyPatterns of treatment response in newly diagnosed epilepsy.Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective.Pharmacokinetics and drug interactions with zonisamide.The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.Lacosamide for the treatment of partial-onset seizures.Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease.Pharmacodynamic and pharmacokinetic interaction of Panchagavya Ghrita with phenytoin and carbamazepine in maximal electroshock induced seizures in ratsPharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide.Correlation between prescribed daily dose, seizure freedom and defined daily dose in antiepileptic drug treatment.[Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany].Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapyExperimental re-evaluation of flunarizine as add-on antiepileptic therapy.Epilepsy and nonlinear dynamics.No pharmacokinetic interaction between lacosamide and carbamazepine in healthy volunteers.Effect of minocycline on pentylenetetrazol-induced chemical kindled seizures in mice.Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin.Utilization patterns of antiepileptic drugs among adult epileptic patients at a tertiary hospital in Oman.Treatment Outcomes in Patients with Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.Selecting Rational Drug Combinations in Epilepsy.Beneficial Combination of Lacosamide with Retigabine in Experimental Animals: An Isobolographic Analysis.How to get the answer to nearly everything: using the internet for epilepsy research.Antiepileptic drugs in critically ill patients.
P2860
Q24629140-2D03E434-4159-44BD-A0D6-25C204A104D3Q33628299-A5A44326-1963-4148-A3F8-3869632267E2Q33664046-276844AD-08BF-403E-AA7A-86CA596E281DQ34329823-96AA78B8-AEEC-4AFA-969A-74F4DD3B7B8FQ34688725-83DDD3DC-05CF-472B-B747-F6543FAF5703Q35245431-FB473C87-4575-43F0-9BB3-CA3AD07186E9Q35664957-F017C93B-5C31-457C-A4A6-90A97CF592E5Q35936036-28D20ABE-23C5-42BE-8460-1B4CF6A15EA9Q35948540-F2E8831F-F843-4BF8-8F26-D7067EB53A15Q36097620-B80E2629-2E6F-4BF3-AA35-B9D8C8282C37Q36744156-97262B3C-B12C-4AC6-89FC-1C19B7E74E65Q37575533-28C3F890-6A15-4125-A200-812BFA747B6BQ38014885-6E201747-5D8D-4A2C-9755-D7CB6865C9F4Q38451960-C604F12B-144F-4857-8EA5-906ECC0CCF62Q38866376-E0C61240-5EE0-414B-A1ED-D14A5924D9F4Q38904679-E9890AB9-DB96-4907-8FE6-1531A03ED3C0Q38931684-14BFC97C-E609-4239-9D0F-D718ACCB0FAEQ40611807-113139A6-64D8-42CD-919A-1AED0B25EFA5Q41376779-8ED0AD32-A277-4997-8F30-9C1022E382A0Q41913572-744287BB-078C-4639-BAF2-6B083469FD2FQ43240944-64111A58-93A2-4ECD-96B6-FD4C1C22BF23Q43258641-0AD9080A-D535-47D4-B5BD-4F613331EB5EQ44523984-210AE0B9-8877-4C0C-B514-8E8FA373B7F7Q45723444-25D7C65C-02AE-433A-B650-0618205C6494Q46489939-89F6939E-9E2D-4436-BD07-B0E577E5D68EQ47245856-41E8C2C8-AFFD-432D-BEBB-E45E9EF647D3Q47869836-E8D19425-4E2E-48A3-9E59-53A181692DB6Q48105985-766C1777-7234-41CD-BF99-F07048ED9502Q53184071-7CDF5B19-F505-4923-B556-FCAD5C0659DAQ55190397-67F5FE75-2E86-4115-B64B-7946B9137617
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Combination therapy in epilepsy: when and what to use.
@ast
Combination therapy in epilepsy: when and what to use.
@en
type
label
Combination therapy in epilepsy: when and what to use.
@ast
Combination therapy in epilepsy: when and what to use.
@en
prefLabel
Combination therapy in epilepsy: when and what to use.
@ast
Combination therapy in epilepsy: when and what to use.
@en
P2860
P1433
P1476
Combination therapy in epilepsy: when and what to use.
@en
P2093
Martin J Brodie
Patrick Kwan
P2860
P304
P356
10.2165/00003495-200666140-00004
P577
2006-01-01T00:00:00Z
P6179
1052327711